MAP3K7 and ischemic stroke: Several studies have proven that TAK1 is rapidly activated in ischemic stroke, and inhibition of TAK1 both via conditional knockout and via treatment with 5Z-7-oxozeaenol can reduce infarct volume and cell death and improve neurological outcomes [47, 48].